Noémie Calland

Most-cited papers

1. (−)‐Epigallocatechin‐3‐gallate is a new inhibitor of hepatitis C virus entry

   Noémie Calland, A. Albecka, S. Belouzard, C. Wychowski +6 more

   2012Hepatology254 citations Open access

   Semantic Scholar

   Save

2. Hepatitis C Virus and Natural Compounds: a New Antiviral Approach?

   Noémie Calland, J. Dubuisson, Y. Rouillé, K. Séron

   2012Viruses128 citations Open access

   Semantic Scholar

   Save

3. Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action

   Noémie Calland, M. Sahuc, S. Belouzard, V. Pène +14 more

   2015Journal of Virology118 citations Open access

   Semantic Scholar

   Save

4. The antimalarial ferroquine is an inhibitor of hepatitis C virus†, ‡

   Thibaut Vausselin, Noémie Calland, S. Belouzard, V. Descamps +12 more

   2013Hepatology41 citations Open access

   Semantic Scholar

   Save

5. New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A

   Lucie Fénéant, Julie Potel, C. François, F. Sané +13 more

   2015Journal of Virology22 citations Open access

   Semantic Scholar

   Save

6. Potent antiviral activity of Solanum rantonnetii and the isolated compounds against hepatitis C virus in vitro

   Khaled Rashed, M. Sahuc, Gaspard Deloison, Noémie Calland +3 more

   201416 citations Open access

   Semantic Scholar

   Save

7. Specialization of Hepatitis C Virus Envelope Glycoproteins for B Lymphocytes in Chronically Infected Patients

   F. Douam, L. Bobay, G. Maurin, J. Fresquet +6 more

   2015Journal of Virology12 citations Open access

   Semantic Scholar

   Save

8. Analysis of Serine Codon Conservation Reveals Diverse Phenotypic Constraints on Hepatitis C Virus Glycoprotein Evolution

   Richard J. P. Brown, G. Koutsoudakis, R. Urbanowicz, D. Mirza +18 more

   2013Journal of Virology3 citations Open access

   Semantic Scholar

   Save